The workflow of TNF-α inhibitor prediction in RA.
5
$ 14.99
In stock
(163)
Product Description
Pathogenetic insights from the treatment of rheumatoid arthritis - The Lancet
Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial - The Lancet
Pathogenic TNF-α drives peripheral nerve inflammation in an Aire-deficient model of autoimmunity
Coagulation and Endothelial Dysfunction Associated with NAFLD: Current Status and Therapeutic Implications
Updated rheumatoid arthritis treatment recommendations
Discovery of an Orally Active Small-Molecule Tumor Necrosis Factor-α Inhibitor
The workflow of TNF-α inhibitor prediction in RA.
Modulation of T-cell responses by anti-tumor necrosis factor treatments in rheumatoid arthritis: a review, Arthritis Research & Therapy
IJMS, Free Full-Text
The role of gut microbiota in T cell immunity and immune mediated disorders
/cdn.vox-cdn.com/uploads/chorus_image/image/72674420/1229683197.0.jpg "Giants vs 49ers NFL Week 3 Thursday Night Football picks and")
